Stay updated on Zolbetuximab Combo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab Combo in Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-13T22:57:34.000Z thumbnail image
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Last Update Posted (Estimated) has been updated to Last Update Posted. This change indicates that the last update posted on the webpage is now the actual posted update, rather than an estimated one.
    Difference
    0.0%
    Check dated 2024-06-12T21:44:57.000Z thumbnail image
  4. Check
    4 days ago
    Change Detected
    Summary
    The value of the Last Update Posted has changed from 2024-05-20 to 2024-06-10. This update represents a recent change in the information provided on the webpage.
    Difference
    0.3%
    Check dated 2024-06-11T21:10:22.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a significant update in the study details of a Phase 3 clinical trial for Zolbetuximab (IMAB362) plus mFOLFOX6 versus placebo plus mFOLFOX6 in subjects with Claudin 18.2 positive, HER2-negative, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.
    Difference
    0.0%
    Check dated 2024-06-06T14:29:25.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, including specific health conditions and prior treatments required for inclusion. The new criteria emphasize the importance of pregnancy status, contraceptive use, and specific health metrics for both female and male subjects.
    Difference
    30%
    Check dated 2024-05-22T21:02:57.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 04 30 05 04 26 04 30 04 to 05 20 03 05 17 05 20 05. This change likely represents an update or modification in the data related to a Phase 3 clinical study of Zolbetuximab plus mFOLFOX6 versus placebo plus mFOLFOX6 for the treatment of gastric and gastroesophageal junction cancer.
    Difference
    0.4%
    Check dated 2024-05-21T14:31:31.000Z thumbnail image

Stay in the know with updates to Zolbetuximab Combo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.